D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
ARCT holding history
Arcturus Therapeutics Holdings Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ARCT overviewAll 13F holders of ARCTFull Q2 2026 holdings
- Shares (Q2 2026)
- 392,358
- Value
- $2.64M
- % of portfolio
- <0.1%
- Quarters held
- 13
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 392,358 | $2.64M | <0.1% | +140,324+55.7% | Added | Holders |
| Q1 2026 | 252,034 | $1.95M | <0.1% | +154,211+157.6% | Added | Holders |
| Q4 2025 | 97,823 | $599.7K | <0.1% | +37,610+62.5% | Added | Holders |
| Q3 2025 | 60,213 | $1.11M | <0.1% | +49,776+476.9% | Added | Holders |
| Q2 2025 | 10,437 | $135.8K | <0.1% | +10,437 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −10,355−100.0% | Sold out | Holders |
| Q1 2024 | 10,355 | $349.7K | <0.1% | −63,440−86.0% | Reduced | Holders |
| Q4 2023 | 73,795 | $2.33M | <0.1% | +29,166+65.4% | Added | Holders |
| Q3 2023 | 44,629 | $1.14M | <0.1% | −57,458−56.3% | Reduced | Holders |
| Q2 2023 | 102,087 | $2.93M | <0.1% | +102,087 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −128,363−100.0% | Sold out | Holders |
| Q4 2021 | 128,363 | $4.75M | <0.1% | +32,597+34.0% | Added | Holders |
| Q3 2021 | 95,766 | $4.58M | <0.1% | −209,324−68.6% | Reduced | Holders |
| Q2 2021 | 305,090 | $10.3M | <0.1% | +225,152+281.7% | Added | Holders |
| Q1 2021 | 79,938 | $3.30M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.